Clinical Trial:

Chronic ITP registry (PRO00000924)

Full Name
PARC-ITP Study Pediatric and adult intercontinental registry on chronic ITP

Description

Demographic information will be collected from participants and de-identified before submitting to the registry. Participants have the option of consenting to provide a 3-5ml blood sample, which will be analyzed to determine genetic variants that may play a role in ITP. The assessment of genetic markers may help predict risk of chronic relapsing ITP, risk of developing severe ITP, and likelihood of response to treatment. The blood sample is voluntary; participants who do not consent to it may participate in the registry only.

Eligibility

Inclusion Criteria
  • Age of 2 months to 21 years old
  • Newly diagnosed ITP